Thomas L. Vaughan
M.P.H., University of Washington, 1983.
M.D., University of Illinois, 1978.
B.S., Cornell University, Biomedical Engineering, 1974.
For a full description of research interests and a list of publications, see research website under "contact information" above.
Long-Chain Omega-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer.. Nutrition and cancer.. 2013.
Diet and upper gastrointestinal cancers: in search of dark matter.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 11(9):1137-9.. 2013.
Association Between Markers of Obesity and Progression From Barrett's Esophagus to Esophageal Adenocarcinoma.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.. 2013.
NSAIDs Modulate Clonal Evolution in Barrett's Esophagus.. PLoS genetics. 9(6):e1003553.. 2013.
Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.. Seminars in radiation oncology. 23(1):3-9.. 2013.
Specialty supplement use and biologic measures of oxidative stress and DNA damage.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2013.
Recent Physical Activity in Relation to DNA Damage and Repair Using the Comet Assay.. Journal of physical activity & health.. 2013.
Spectrum and risk of neoplasia in Werner syndrome: a systematic review.. PloS one. 8(4):e59709.. 2013.
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.. Nature genetics. 44(10):1131-1136.. 2012.
A Clinical Risk Prediction Model for Barrett Esophagus.. Cancer prevention research (Philadelphia, Pa.). 5(9):1115-1123.. 2012.
Non-Steroidal Anti-Inflammatory Drug Use Reduces Risk for Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis.. Gastroenterology. 142(3):442-452.e5.. 2012.
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(3):456-461.. 2012.
Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium.. Cancer causes & control : CCC. 23(1):69-88.. 2012.
History of Diabetes and Risk of Head and Neck Cancer: A Pooled Analysis from the International Head and Neck Cancer Epidemiology Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(2):294-304.. 2012.
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium.. International journal of epidemiology. 41(6):1706-1718.. 2012.
Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women.. Cancer prevention research (Philadelphia, Pa.). 4(6):840-50.. 2011.
MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction.. The American journal of surgical pathology. 35(7):1007-13.. 2011.
Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer.. Annals of epidemiology. 21(7):543-50.. 2011.